Efficacy of Cardioprotective Drugs in Cancer Patients Receiving Anthracyclines: A Pairwise Meta-Analysis and Network Meta-Analysis.
Anthracyclines are cornerstone chemotherapeutic agents for several cancers but carry a substantial risk of cardiotoxicity. Multiple cardioprotective drugs have been investigated to prevent cardiac dysfunction in patients receiving anthracycline-based chemotherapy. This study evaluated and ranked the cardioprotective ef...